| Product NDC: | 29336-540 |
| Proprietary Name: | Norflex |
| Non Proprietary Name: | orphenadrine citrate |
| Active Ingredient(s): | 60 mg/2mL & nbsp; orphenadrine citrate |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 29336-540 |
| Labeler Name: | Graceway Pharmaceuticals, LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA013055 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100525 |
| Package NDC: | 29336-540-06 |
| Package Description: | 6 AMPULE in 1 BOX (29336-540-06) > 2 mL in 1 AMPULE |
| NDC Code | 29336-540-06 |
| Proprietary Name | Norflex |
| Package Description | 6 AMPULE in 1 BOX (29336-540-06) > 2 mL in 1 AMPULE |
| Product NDC | 29336-540 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | orphenadrine citrate |
| Dosage Form Name | INJECTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS |
| Start Marketing Date | 20100525 |
| Marketing Category Name | NDA |
| Labeler Name | Graceway Pharmaceuticals, LLC |
| Substance Name | ORPHENADRINE CITRATE |
| Strength Number | 60 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |